The efficacy of desvenlafaxine for improving functioning and quality of life measures in patients with major depressive disorder

被引：0
|
作者：
Soares, C.
Thase, M. [1 ]
Kornstein, S. [2 ]
Brisard, C. [3 ]
Septien-Velez, L. [3 ]
Germain, J. M. [3 ]
Pitrosky, B. [3 ]
Patroneva, A. [4 ]
Jiang, Q. [4 ]
Ninan, P. [4 ]
Ganguly, R. [4 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[3] Wyeth Ayerst Res, Paris, France
[4] Wyeth Ayerst Res, Collegeville, PA USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70478-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S342 / S343
页数：2
相关论文
共 50 条
  • [31] Predicting functioning and quality of life using objective and subjective measures of sleep and biological rhythms in major depressive and bipolar disorder
    Slyepchenko, A.
    Allega, O. R.
    Leng, X.
    Minuzzi, L.
    Eltayebani, M. M.
    Skelly, M.
    Sassi, R. B.
    Soares, C. N.
    Kennedy, S. H.
    Frey, B. N.
    BIPOLAR DISORDERS, 2019, 21 : 58 - 58
  • [32] Duloxetine and improvement of quality of life in patients with major depressive disorder
    Choustoulakis, I.
    Georgopoulou, A.
    Bornivelli, C.
    Karkazis, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S337 - S337
  • [33] Improvements in quality of life with desvenlafaxine 50 mg/d vs placebo in employed adults with major depressive disorder
    Endicott, Jean
    Lam, Raymond W.
    Hsu, Ming-Ann
    Fayyad, Rana
    Boucher, Matthieu
    Guico-Pabia, Christine J.
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 166 : 307 - 314
  • [34] Efficacy and safety of desvenlafaxine for prevention of relapse in adult outpatients treated for major depressive disorder
    Rosenthal, J.
    Boyer, P.
    Vialet, C.
    Hwang, E.
    Tourian, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S171 - S171
  • [35] Assessing the Efficacy of Desvenlafaxine for Improving Functioning and Well-Being Outcome Measures in Patients With Major Depressive Disorder: A Pooled Analysis of 9 Double-Blind, Placebo-Controlled, 8-Week Clinical Trials
    Soares, Claudio N.
    Kornstein, Susan G.
    Thase, Michael E.
    Jiang, Qin
    Guico-Pabia, Christine J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (10) : 1365 - 1371
  • [36] Pharmacotherapy of Major Depressive Disorder: Focus on Desvenlafaxine Succinate
    Trinidad, Antolin C.
    Bregman, Benjamin
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 381 - 385
  • [37] Relationship between work functioning and self-reported cognitive complaints in patients with major depressive disorder treated with desvenlafaxine
    Alonso-Prieto, Esther
    Rubino, Cristina
    Lucey, Megan
    Evans, Vanessa C.
    Tam, Edwin M.
    Woo, Cindy
    Iverson, Grant L.
    Chakrabarty, Trisha
    Yatham, Lakshmi N.
    Lam, Raymond W.
    PSYCHIATRY RESEARCH, 2019, 272 : 144 - 148
  • [38] An integrated analysis of the efficacy of desvenlafaxine succinate compared with placebo in the treatment of major depressive disorder
    Thase, M. E.
    Kornstein, S. G.
    Tummala, R.
    Germain, J. M.
    Jiang, Q.
    Ahmed, S.
    Ninan, P. T.
    EUROPEAN PSYCHIATRY, 2008, 23 : S208 - S208
  • [39] A Pooled Analysis of the Efficacy of Desvenlafaxine for the Treatment of Major Depressive Disorder in Perimenopausal and Postmenopausal Women
    Kornstein, Susan G.
    Clayton, Anita H.
    Bao, Weihang
    Guico-Pabia, Christine J.
    JOURNAL OF WOMENS HEALTH, 2015, 24 (04) : 281 - 290
  • [40] Quality of life and subjective sleep-related measures in bipolar disorder and major depressive disorder
    Françoise Jermann
    Nader Perroud
    Sophie Favre
    Jean-Michel Aubry
    Hélène Richard-Lepouriel
    Quality of Life Research, 2022, 31 : 117 - 124
12345